Artemis Wealth Advisors, LLC Novartis Ag Transaction History

Artemis Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Sep 11, 2023	BUY	$83.5 - $98.47 $49,014 - $57,801	587 New	587 $50,000
Q1 2020 Sep 05, 2023	BUY	$70.67 - $99.01 $41,483 - $58,118	587 New	587 $48,000
Q1 2020 Feb 17, 2023	BUY	$70.67 - $99.01 $41,483 - $58,118	587 New	587 $48,000
Q4 2019 Sep 01, 2023	BUY	$84.35 - $95.37 $49,513 - $55,982	587 New	587 $55,000
Q4 2019 Feb 13, 2023	BUY	$84.35 - $95.37 $49,513 - $55,982	587 New	587 $56,000

1,446

130M

1.12M

1.61M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.